Guardant Health Inc logo

GH - Guardant Health Inc News Story

$120.2 -3.5  -2.8%

Last Trade - 18/06/21

Large Cap
Market Cap £8.99bn
Enterprise Value £8.45bn
Revenue £214.0m
Position in Universe 838th / 6919

Guardant Health Inc reports results for the quarter ended in March - Earnings Summary

Fri 7th May, 2021 7:46pm
* Guardant Health Inc  GH.OQ  reported a quarterly adjusted loss
of $1.09​​ per share for the quarter ended in March. The mean
expectation of eleven analysts for the quarter was for a loss
of 89 cents per share.
* Revenue rose 16.5% to $78.67 million from a year ago​; 
analysts expected $73.75 million.
* Guardant Health Inc's reported EPS for the quarter was a loss
of $1.09​.
* The mean earnings estimate of analysts had fallen by
about 87.1% in the last three months.​ 
* In the last 30 days there have been no negative revisions of
earnings estimates and  
* Guardant Health Inc shares had fallen by 11.8% this
quarter and gained 4.5% so far this year.
* The company reported a quarterly loss of $109.66 million.
* Wall Street's median 12-month price target for Guardant Health
Inc is $175.50 
* The current average analyst rating on the shares is "strong
buy" and the breakdown of recommendations is 12 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 
This summary was machine generated May 7 at 06:46 p.m. GMT. ​All
figures in US Dollars.​
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.